APA (7th ed.) Citation

Masuda, N., Ohtani, S., Nagai, S., Takashima, S., Yamaguchi, M., Tsuneizumi, M., . . . Takahashi, M. (2019). 353P - Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer: Results of single arm phase IV COMACHI study. Annals of Oncology, 30, v127. https://doi.org/10.1093/annonc/mdz242.048

Chicago Style (17th ed.) Citation

Masuda, N., et al. "353P - Pertuzumab, Trastuzumab, and Docetaxel for HER2-positive Metastatic Breast Cancer: Results of Single Arm Phase IV COMACHI Study." Annals of Oncology 30 (2019): v127. https://doi.org/10.1093/annonc/mdz242.048.

MLA (9th ed.) Citation

Masuda, N., et al. "353P - Pertuzumab, Trastuzumab, and Docetaxel for HER2-positive Metastatic Breast Cancer: Results of Single Arm Phase IV COMACHI Study." Annals of Oncology, vol. 30, 2019, p. v127, https://doi.org/10.1093/annonc/mdz242.048.